Depends entirely on whether your specific cancer came from an inherited gene change or not, most don’t. Your family should really only consider testing if your own genetic test turned up a harmful mutation, or if something about your diagnosis raises a flag, being unusually young at diagnosis, or a strong pattern of the same cancer running through the family.

According to Dr. Sandeep Nayak, surgical oncologist in Bangalore with over 24 years of experience treating solid tumors, “Patients assume every cancer is hereditary, and it’s just not true, most aren’t. What actually matters is whether we’ve found a specific mutation in you. If we have, that’s when the conversation with your family becomes worth having. Without that, we’d just be creating anxiety without any real answer behind it.”

• Your own genetic test came back positive for a known mutation, BRCA1, BRCA2, Lynch syndrome, or similar.
• You were diagnosed at an unusually young age for that particular cancer type.
• Multiple close relatives, parents, siblings, children, have had the same or related cancers.
• You have a specific cancer type known to run in hereditary patterns, certain breast, ovarian, or colorectal cancers especially.

Hereditary breast and ovarian cancer syndromes come up often enough in practice that they’re worth understanding on their own, our Breast Cancer treatment page goes into how a positive result can actually change surgical decisions too.

A positive result doesn’t mean they’ll definitely get cancer, it means their risk is higher than average.

• Increased screening usually starts, often earlier and more frequently than standard guidelines.
• Some relatives choose preventive options depending on the specific mutation and their own risk tolerance.
• A negative result in a family with a known mutation is genuinely reassuring, it usually means that person’s risk drops back to average.

This is exactly the kind of decision that benefits from genetic counselling before testing even happens, not just after, so the results actually mean something once you have them.

Dr. Sandeep Nayak has spent more than two decades in surgical oncology, and genetic testing has increasingly become part of how treatment decisions get made, not just an afterthought once surgery’s already planned. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to patients isn’t the title though, it’s that the conversation about family risk doesn’t stop once their own treatment is decided. That follow-through is often where things get missed elsewhere.

Not sure if your family should be tested? Don’t guess at this one. Call +91 9482202240 and get someone to actually walk you through it.

References

• NCI — Cancer Genetics Risk Assessment and Counseling
•  ASCO — Clinical Practice Guidelines

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Yes, in most cases it can be, though it really depends on the specifics. Which treatment, how advanced the cancer is, and which trimester you’re in, all of it changes what’s actually possible. This isn’t a one-size-fits-all answer, it takes a team, cancer specialists and pregnancy experts working the plan out together, step by step.

According to Dr. Sandeep Nayak, surgical oncologist in Bangalorewith over 24 years of experience treating solid tumors, “This is one of the most frightening moments a patient can walk into my clinic with, and I understand why. But waiting isn’t automatically safer, and treating isn’t automatically risky. Every case needs its own plan, built around the cancer and the pregnancy together, not one at the expense of the other.”

• The trimester matters a lot. Surgery is generally considered safer throughout pregnancy, while chemotherapy is usually avoided in the first trimester due to higher risk to the developing baby.
• Cancer type and stage change everything, some cancers can wait a few weeks safely, others genuinely can’t.
• Radiation therapy is the trickiest one, often delayed until after delivery unless the situation is urgent.
• Every decision here gets made jointly, oncology and obstetrics, not oncology alone.

This kind of case comes up more often with pregnancy-associated breast cancer specifically, and if that’s your situation, our Breast Cancer treatment page goes into the surgical side of it in more depth.

• • Surgery is usually possible in any trimester, with anaesthesia protocols adjusted specifically for pregnancy.
  • Chemotherapy, when needed, is generally given from the second trimester onward, once the highest-risk period for the baby has passed.
  • Certain chemotherapy drugs are considered safer than others during pregnancy, this isn’t a blanket yes or no.
  • Delivery timing sometimes gets planned around the treatment schedule itself, not just around the due date.

  Once treatment’s done and you’re thinking further ahead, we’ve written about the other side of this question in Is Pregnancy Safe After Cancer Treatment?, worth reading if pregnancy after treatment is something you’re planning for.

Dr. Sandeep Nayak has spent more than two decades in surgical oncology, and cases involving cancer during pregnancy, where timing and precision matter more than almost anywhere else, have been part of that work throughout. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to patients isn’t the title though, it’s that he works the plan out jointly with the obstetric team from day one, rather than treating the cancer and the pregnancy as two separate problems being managed in parallel. That coordination is often where things get missed elsewhere.

Diagnosed during pregnancy and not sure what happens next? Don’t sit on it waiting for more clarity to arrive on its own. Call +91 9482202240 and get someone to actually walk you through it.

Reference

• American Cancer Society — Treating Breast Cancer During Pregnancy:
  Treating Breast Cancer During Pregnancy — American Cancer Society
• National Cancer Institute — Breast Cancer During Pregnancy:
  Breast Cancer During Pregnancy — NCI

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Yes, and it’s one of the more overlooked steps in early cancer planning. Chemotherapy and radiation can damage reproductive cells, sometimes permanently, so freezing eggs, embryos, or sperm before treatment starts is the way most patients protect that option for later. It’s a proven, established process at this point, not experimental.

According to Dr. Sandeep Nayak, surgical oncologist in Bangalore with over 24 years of experience treating solid tumors, “This conversation gets missed more often than it should, mostly because everyone’s focused on treating the cancer itself, understandably. But fertility preservation has a narrow window, it needs to happen before chemo or radiation starts, not after. I’d rather bring it up on day one than have a patient ask about it two years down the line.”

• Sperm banking is fast, usually done in a single visit, and doesn’t delay the start of cancer treatment by more than a day or two.
• Egg freezing takes longer, typically 10 to 14 days of hormonal stimulation before eggs can be retrieved.
• Embryo freezing follows a similar timeline to egg freezing, just with fertilisation added before storage.
• Timing has to be coordinated closely with your oncology team, since treatment can’t always wait for a full stimulation cycle.

A surgical oncologist usually flags this option early and loops in a fertility specialist before treatment planning is finalised, rather than leaving it as an afterthought.

• Not every treatment plan affects fertility the same way, some chemotherapy drugs carry higher risk than others.
• Radiation to the pelvis tends to carry more fertility risk than radiation elsewhere in the body.
• Age at the time of treatment plays a role too, particularly for egg freezing outcomes.
• Even if pregnancy feels like a distant question right now, preserving the option costs far less than trying to recover it later.

If you’re further along and thinking about the other side of this question, we’ve covered that in Is Pregnancy Safe After Cancer Treatment?, worth a read once treatment’s behind you and you’re planning the next step.

Dr. Sandeep Nayak has spent more than two decades in surgical oncology, and young patients facing treatment that could affect fertility have been part of that work throughout. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to patients isn’t the title though, it’s that he brings up fertility preservation on day one, before treatment planning gets finalised, rather than leaving it as something to circle back to later. That early conversation is often where things get missed elsewhere.

References

• ASCO — Clinical Practice Guidelines:
  ASCO Guidelines — Fertility Preservation
• National Cancer Institute (NCI) — Female Fertility and Cancer Treatment:
  NCI — Female Fertility and Cancer Treatment

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Yes, and it’s actually done fairly often now. Doctors call it perioperative therapy, which just means immunotherapy gets timed around the surgery itself rather than replacing it. Sometimes it’s given beforehand (neoadjuvant) to shrink the tumour down first. Sometimes after (adjuvant), to mop up whatever cells surgery couldn’t catch. Occasionally both, if the case calls for it, mainly to cut down the odds of the cancer coming back.

According to Dr. Sandeep Nayak, surgical oncologist in Bangalorewith over 24 years of experience treating solid tumors, “Surgery removes what we can see and immunotherapy goes after what we can’t. Used together, with the right timing, they cover more ground than either one manages alone. The mistake is treating this as an either-or decision. It rarely is.”

• Given to shrink a tumour down to a size where surgery becomes safer or even possible in the first place.
• Can turn a borderline-inoperable tumour into one that’s actually removable.
• Response gets tracked through imaging before the surgery date is even fixed.
• Not every cancer type responds the same way, so this call goes through a tumour board first.

This decision follows the same underlying logic as chemo timing before surgery, just with a different drug class doing the work.

• Targets whatever microscopic cancer cells imaging couldn’t pick up after the tumour’s already out.
• Lowers the chance of recurrence, particularly in cancers with a known relapse pattern.
• Usually starts once the surgical site has had enough time to heal properly.
• Duration varies a lot, some protocols run months, others longer, depending on the cancer type and how the case responds.

A surgical oncologist coordinates this timing with the rest of the treatment team, since jumping in too early can interfere with recovery.

Dr. Sandeep Nayak has spent more than two decades in surgical oncology, and cases needing immunotherapy worked into the treatment sequence, before surgery, after, or both, have been part of that work throughout. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to patients isn’t the title though, it’s that every case still goes through tumour board before that sequence gets decided, surgery and medical oncology figuring it out together rather than surgery being planned in isolation. That coordination is often where things get missed elsewhere.

Not sure where immunotherapy fits into your treatment plan? Don’t let that decision get made without the full picture. Call +91 9482202240 and get someone to actually walk you through it.

Reference

Immunotherapy to Treat Cancer — National Cancer Institute
ASCO Clinical Practice Guidelines

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

For average-risk adults, routine colonoscopy screening should start at 45, not 50. That’s the shift worth knowing about. Leading Indian hospitals and global oncology bodies moved the baseline down a few years back, mainly because colorectal cancer cases in younger adults kept climbing and the old cutoff was missing too many of them.

According to Dr. Sandeep Nayak, surgical oncologist in Bangalorewith over 24 years of experience treating solid tumors, “I’ve operated on colorectal cancer patients in their early 30s more times than I’d like. The old rule of waiting till 50 was built for a different disease pattern than what we’re actually seeing walk through the door now. Age 45 isn’t some arbitrary new number, it’s catching up to what’s actually happening.”

• Colorectal cancer in adults under 50 has been rising steadily across India, not just in the West.
• A meaningful share of new cases now show up in people in their 30s and early 40s, sometimes without any family history at all.
• Diet shifts, sedentary jobs, obesity, and processed food intake all get flagged as contributing factors, though no single one explains it fully.
• Catching it early still makes the biggest difference. Stage 1 colorectal cancer has survival rates well above 90 percent, stage 4 is a very different picture.

If any of that sounds like it might already apply to you, symptoms, family history, or otherwise, it’s worth going through our Colon Cancer treatment page directly rather than waiting on a routine screening date.

• Anyone with a first-degree relative (parent, sibling, child) who’s had colorectal cancer, screening usually needs to start 10 years before that relative’s age at diagnosis.
• People with inflammatory bowel disease, like ulcerative colitis or Crohn’s, need a different, often earlier schedule entirely.
• A history of Lynch syndrome or other hereditary colorectal cancer syndromes in the family changes the starting age significantly.
• Persistent symptoms, rectal bleeding, unexplained weight loss, or a real change in bowel habits, shouldn’t wait for any screening age at all.

This ties directly into the pattern we’ve written about before, Is Colorectal Cancer More Common in Young Indians Now?, where the shift toward younger diagnoses gets explained in more depth.

Dr. Sandeep Nayak has spent more than two decades in surgical oncology, and colorectal cases have been a consistent part of that work throughout. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to patients isn’t the title though, it’s that every colonoscopy referral and every confirmed diagnosis gets the same structured, diagnostic-first approach, whether it’s a routine screening or something already worrying someone. That consistency is often where things get missed elsewhere.

Got a screening question or something that’s already bothering you? Don’t let it sit there unanswered. Call +91 9482202240 and get someone to actually walk you through it.

References

• American Cancer Society — Colorectal Cancer Screening Guideline (2026):
  ACS Colorectal Cancer Screening Guidelines

• Indian Council of Medical Research (ICMR) — Colorectal Cancer Guideline:
  ICMR Guidelines — Colorectal Cancer

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Here’s the part that catches most women off guard. Pre-cervical cancer, also called cervical dysplasia, and even early-stage cervical cancer usually don’t cause any symptoms at all. There’s no lump to feel, no pain to flag it, nothing obvious that tells you something’s changing. The cells can be shifting toward cancer for years before the body gives any hint, and a Pap smear or HPV test remains the only reliable way to catch it early.

Dr. Sandeep Nayak, surgical oncologist in Bangalore, puts it plainly: “Cervical cancer is one of the few cancers we can genuinely catch before it becomes cancer at all. Waiting for symptoms defeats the entire purpose of screening. By the time symptoms appear, the disease has usually moved past the early stage.”

Once cervical cancer moves beyond the earliest stage, a few signs tend to appear. None of these confirm cancer on their own, but each one is worth getting checked rather than brushed aside.

• Unusual vaginal bleeding, including bleeding between periods, after sex, or after menopause
• Vaginal discharge that looks different than usual, sometimes watery, sometimes with a noticeable odor
• Pelvic pain that isn’t tied to your normal cycle
• Discomfort or bleeding during intercourse

These symptoms overlap with plenty of non-cancerous conditions too, so they’re not proof of anything by themselves. What they do mean is that a visit to a gynecologic oncologist is worth making sooner rather than later. Our cervical cancer treatment program covers diagnosis, staging, and surgical management for exactly this kind of workup.

Screening intervals aren’t one-size-fits-all, but general guidelines look something like this:

• A Pap smear every three years, starting in your early twenties
• An HPV test every five years, starting in your thirties
• Earlier or more frequent testing if you have a prior abnormal result or a family history
• A conversation with your gynecologist if you’re unsure which schedule applies to you

The exact interval matters less than simply not skipping it. This is really the same logic behind checking any silent warning sign early, the kind we talked about in our post on painless lumps and why absence of pain doesn’t mean absence of risk. Cervical cancer just takes that idea one step further, since even the earliest disease often gives no sign at all.

Dr. Sandeep Nayak  has spent more than two decades in surgical oncology, and gynecologic cancers, cervical cancer especially, have been a consistent part of that work. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to patients isn’t the title though, it’s that he stays involved after an abnormal screening result too, not just once surgery becomes the conversation. That follow-through is often where things get missed elsewhere.Got a Pap smear or HPV result that came back abnormal? Don’t let it sit in a folder somewhere. Call +91 9482202240 and get someone to actually look at it.

References

1.  WHO — Cervical Cancer Fact Sheet
2. American Cancer Society — Cervical Cancer Detection, Diagnosis & Staging

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.